|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Premature Ejaculation | |||||
| 2 | Interventions listed in this trial | ||||
| Escitalopram | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Citalopram | |||||
| Dexetimide | |||||
| 4 | More general drug interventions related to this trial | ||||
| Anti-Dyskinesia Agents | |||||
| Antidepressive Agents | |||||
| Antidepressive Agents, Second-Generation | |||||
| Antiparkinson Agents | |||||
| Autonomic Agents | |||||
| Central Nervous System Agents | |||||
| Cholinergic Agents | |||||
| Cholinergic Antagonists | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Muscarinic Antagonists | |||||
| Neurotransmitter Agents | |||||
| Neurotransmitter Uptake Inhibitors | |||||
| Parasympatholytics | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Psychotropic Drugs | |||||
| Serotonin Agents | |||||
| Serotonin Uptake Inhibitors | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| Cairo University | |||||